Skip to main content

Institute for Wealth Management, LLC.

Position in VKTX — Viking Therapeutics, Inc.

CIK 1533954 DENVER, CO

Position in VKTX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$3,537,195
-$259,184 QoQ
Shares Held
108,703
+0.7% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Sep 30, 2025
CallValue
$10,512
CallShares
400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Institute for Wealth Management, LLC. holds $8,961,241 across 5 Biotechnology names. VKTX ranks #1 (39.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VKTX
Viking Therapeutics, Inc.
This page
108,703 $3,537,195

All Filings in VKTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,537,195 108,703
2025-12-31 $3,796,379 107,913
2025-09-30 $2,718,587 103,447
2025-09-30 $10,512 400
2025-06-30 $2,394,990 90,377
2025-03-31 $2,181,638 90,337
2024-12-31 $3,243,424 80,602
2024-09-30 $2,294,164 36,237
2024-06-30 $1,692,079 31,920
2024-03-31 $703,560 8,580
2023-12-31 $221,086 11,880
2023-09-30 $131,511 11,880
2023-06-30 $195,557 12,064
2023-03-31 $204,378 12,275
2022-12-31 $115,385 12,275
2022-09-30 $33,388 12,275
2022-06-30 $35,474 12,275
2022-03-31 $36,825 12,275
2021-12-31 $56,465 12,275
2021-09-30 $77,087 12,275
2021-06-30 $74,126 12,375
2021-03-31 $78,271 12,375
2020-12-31 $69,671 12,375
2020-09-30 $70,794 12,164
2020-06-30 $86,375 11,980
2020-03-31 $56,066 11,980